Prior to the first fall presidential debate, a growing share of voters see the election as a referendum on abortion access, and Vice President Harris holds a strong advantage over former President Trump on the issue. The economy and inflation remain voters’ top issue, and many want to hear the candidates address health care costs.
Intellia Therapeutics’ lonvo-z uses CRISPR to inactivate a gene in the liver to reduce levels of a protein key to the swelling attacks from the rare disease hereditary angioedema. Intellia has filed a regulatory submission for this genetic medicine, which could become the first in vivo gene-editing therapy to land FDA approval. The post Intellia’s…
Cancer drugs are always popular biotech investments, but autoimmune disease also figures prominently in the startup financings announced during the annual J.P. Morgan Healthcare Conference this year. The post JPM Deals Recap: Boston Scientific Acquisition, a Mega Round for Parabalis, Enodia Emerges & More appeared first on MedCity News.
How can AI determine who gets matched to new therapies, who is identified for clinical trials, and how patient tracking is scaled across large populations? Chip is joined by Dr. A.J. Blood, a practicing cardiologist at Brigham and Women’s Hospital and the co-founder and Chief Executive Officer of AIwithCare, a startup company that delivers AI-enabled…
Today I attended the very interesting ISPOR Health Policy Leadership Exchange (HPLE) in Washington DC on the topic of Most Favored Nation (MFN). There were a number of important points made and I’ll summarize a few of them. First, US drug prices are much higher than in other OECD countries. An ASPE report from 2024…
CFO Brian Poff told a recent conference that the Texas-based company is looking to strike other significant deals in the near future.
By embracing innovation, optimizing operations and advocating for change, pharmacy leaders can ensure their organizations are not only prepared for the future but are actively shaping it. The post The Future of Pharmacy is Now – Health Systems Must Act to Drive Innovation, Access and Sustainability appeared first on MedCity News.
By KIM BELLARD One of my frequent laments is that here we are, a quarter of the way into the 21st century, yet too much of our health care system still looks like the 20th century, and not enough like the 22nd century. It’s too slow, too reactive, too imprecise, and uses too much brute…
It’s always fun to chat with Jonathan Bush. You kids today may not remember that he was the first CEO to take a cloud-based (Health 2.0!) company public back in 2007! Athenahealth didn’t end up challenging Epic because a cosmically evil hedge fund took it (and him) down as it was on its way to…
WellTheory launched a postpartum program to help women manage autoimmune symptoms triggered by hormonal changes after childbirth. The post WellTheory Introduces Autoimmune Postpartum Program appeared first on MedCity News.